Athersys (NASDAQ:ATHX) will report earnings after markets close on Tuesday, May 14th. Athersys Incorporated is a biotechnology company. The Company has developed technologies that will help identify gene and related proteins and create synthetic human chromosomes.
Here is your Cheat Sheet to Athersys Earnings:
Earnings Expectations: Analysts expect earnings of $-0.11 per share on revenues of $1.58 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.06 to a loss $0.12. For the current year, the average estimate is a loss of $0.35, which is better than the estimate ninety days ago.
Here’s how Athersys has been performing on an annual basis:
|Revenue ($) in millions||3.11||2.16||8.94||10.34||8.71|
|Diluted EPS ($)||-0.95||-0.81||-0.60||-0.59||-0.45|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||2.57||2.75||2.66||1.02||2.29|
|Diluted EPS ($)||-0.1767||-0.17||-0.13||-0.12||-0.0712|
Athersys has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)